Detailed answers about COVINO BIOTECHNOLOGY LIMITED, including incorporation, status, business activity, and accounts information.
When was COVINO BIOTECHNOLOGY LIMITED founded?
COVINO BIOTECHNOLOGY LIMITED was officially incorporated on 19 November 2021 and is registered under company number 13754493. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is COVINO BIOTECHNOLOGY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of COVINO BIOTECHNOLOGY LIMITED?
COVINO BIOTECHNOLOGY LIMITED's current status is Active - Proposal to Strike off. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does COVINO BIOTECHNOLOGY LIMITED do?
COVINO BIOTECHNOLOGY LIMITED operates in the following sectors: 22230 - Manufacture of builders ware of plastic, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 72110 - Research and experimental development on biotechnology. These SIC codes provide insight into the company's business activities and industry focus.
What is COVINO BIOTECHNOLOGY LIMITED's registered address?
The registered office address of COVINO BIOTECHNOLOGY LIMITED is CHASE BUSINESS CENTRE, 39-41 CHASE SIDE, LONDON, UNITED KINGDOM, N14 5BP. This is the official address filed with Companies House for legal and statutory correspondence.
Is COVINO BIOTECHNOLOGY LIMITED financially stable?
The most recent accounts for COVINO BIOTECHNOLOGY LIMITED were made up to 30 November 2024, filed as DORMANT. Next accounts are due by 31 August 2026.